Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Rome, Italy.
Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Rome, Italy.
Surg Obes Relat Dis. 2022 Jul;18(7):983-996. doi: 10.1016/j.soard.2022.03.022. Epub 2022 Apr 20.
With the prevalence of obesity alarmingly increasing, it is of primary interest to identify those factors predicting the success of anti-obesity therapeutic strategies currently adopted in clinical practice, and in particular, those of bariatric procedures showing the greatest success in terms of weight loss and maintenance in both the short and long term. Given sex-related differences in psychosocial status, hormonal homeostasis, and body fat distribution, it is likely that the response to different weight management strategies differs by sex. The objective was to elucidate the effect of sex on different bariatric procedures' efficacy and safety outcomes. Searches of PubMed, Cochrane, and Embase databases were performed, followed by hand-searching of reference lists from all relevant articles. We included all the studies evaluating the effect of bariatric procedures on body mass index loss (BMIL), and/or percentage excess weight loss (%EWL), and/or percentage excess body mass index loss, and/or percentage of responders, and/or short-/long-term complications and co-morbidity resolution, broken down by sex. Twenty-seven studies with a total of 114,919 patients were included. Men were more likely to achieve greater BMIL, consistent with higher male baseline BMI, and women were 2.87 times more likely to be classified as weight responders (95% confidence interval [CI]: 1.90-4.34), as well as to perform better in terms of %EWL (95% CI: .13-.54). Upon subgroup analysis based on bariatric procedure, women were more likely to be successful in terms of %EWL upon bioenteric intragastric balloon (BIB) placement (.72, 95% CI: .42-1.02). There was no sex difference regarding investigated co-morbidity resolution (hypertension, diabetes, and obstructive sleep apnea syndrome) or occurrence of short-term complications, whereas women were more likely to develop long-term complications, with an odds ratio of 1.97 (95% CI: 1.57-2.49). Sex does not have a clear effect on efficacy outcomes of bariatric procedures. Differentiating by procedure, BIB may be more effective in women, although results are discordant based on the weight loss outcome considered. If the short-term postoperative complication rate is similar across both sexes, long-term complications occur more frequently in women. To clarify the real effect of sex on bariatric procedure-derived health benefits, it is crucial to report sex-stratified results in future studies, as well as evaluate body composition changes that go beyond simple body weight reduction.
随着肥胖症的患病率惊人地上升,确定那些预测目前临床实践中采用的抗肥胖治疗策略成功的因素变得至关重要,特别是那些在短期和长期内体重减轻和维持方面取得最大成功的减肥手术。鉴于性别相关的心理社会状态、激素平衡和体脂分布差异,不同的体重管理策略对性别的反应可能不同。目的是阐明性别对不同减肥手术效果和安全性结果的影响。对 PubMed、Cochrane 和 Embase 数据库进行了检索,然后对所有相关文章的参考文献进行了手工检索。我们纳入了所有评估减肥手术对体重指数减轻(BMIL)、超重体重减轻百分比(%EWL)、超重体重指数减轻百分比、应答者百分比、短期/长期并发症和合并症缓解的影响的研究,按性别进行了细分。共纳入 27 项研究,共计 114919 例患者。男性更有可能实现更大的 BMIL,这与更高的男性基线 BMI 一致,而女性成为体重应答者的可能性是男性的 2.87 倍(95%置信区间[CI]:1.90-4.34),以及在 %EWL 方面表现更好(95% CI:.13-.54)。基于减肥手术的亚组分析,女性在生物可吸收胃内球囊(BIB)放置方面更有可能在 %EWL 方面取得成功(.72,95%CI:.42-1.02)。在调查的合并症缓解(高血压、糖尿病和阻塞性睡眠呼吸暂停综合征)或短期并发症的发生方面,性别没有差异,而女性更有可能发生长期并发症,优势比为 1.97(95%CI:1.57-2.49)。性别对减肥手术的疗效结果没有明显影响。按手术方式细分,BIB 可能对女性更有效,尽管基于考虑的减肥效果结果不一致。如果两种性别的短期术后并发症发生率相似,则女性长期并发症更常见。为了阐明性别对减肥手术带来的健康益处的实际影响,在未来的研究中报告按性别分层的结果以及评估超出简单体重减轻的身体成分变化至关重要。